Lexicon Pharmaceuticals (LXRX) Insider Trading & Ownership $0.66 +0.05 (+7.56%) Closing price 05/22/2025 04:00 PM EasternExtended Trading$0.64 -0.02 (-2.27%) As of 05/22/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lexicon Pharmaceuticals (NASDAQ:LXRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.50%Number OfInsiders Buying(Last 3 Years)5Amount OfInsider Buying(Last 3 Years)$113.70 MNumber OfInsiders Selling(Last 3 Years)0 Get LXRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Lexicon Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address LXRX Insider Buying and Selling by Quarter Lexicon Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/16/2023Lonnel CoatsCEOBuy90,000$1.05$94,500.00 11/10/2023Lonnel CoatsCEOBuy10,000$1.01$10,100.00 10/12/2023Raymond DebbaneDirectorBuy148,820$1.03$153,284.60 10/10/2023Raymond DebbaneDirectorBuy508,306$1.14$579,468.84 9/14/2023Jeffrey L WadeCFOBuy10,000$1.38$13,800.00 8/4/2023Wendy McdermottVPBuy6,000$1.84$11,040.00 6/29/2023Lonnel CoatsCEOBuy10,000$2.16$21,600.00 6/26/2023Lonnel CoatsCEOBuy10,000$2.18$21,800.00 6/23/2023Wendy McdermottVPBuy10,000$2.43$24,300.00 6/22/2023Lonnel CoatsCEOBuy40,000$2.31$92,400.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 6/20/2023Jeffrey L WadeCFOBuy12,000$2.33$27,960.00 6/5/2023International S.C.A. ArtalDirectorBuy27,775,050$2.60$72,215,130.00 8/1/2022International S.C.A. ArtalDirectorBuy16,173,800$2.50$40,434,500.00 (Data available from 1/1/2013 forward) LXRX Insider Trading Activity - Frequently Asked Questions Who is on Lexicon Pharmaceuticals's Insider Roster? The list of insiders at Lexicon Pharmaceuticals includes International S.C.A. Artal, Jeffrey L Wade, Lonnel Coats, Raymond Debbane, and Wendy Mcdermott. Learn more on insiders at LXRX. What percentage of Lexicon Pharmaceuticals stock is owned by insiders? 4.50% of Lexicon Pharmaceuticals stock is owned by insiders. Learn more on LXRX's insider holdings. Which Lexicon Pharmaceuticals insiders have been buying company stock? The following insiders have purchased LXRX shares in the last 24 months: International S.C.A. Artal ($72,215,130.00), Jeffrey L Wade ($41,760.00), Lonnel Coats ($240,400.00), Raymond Debbane ($732,753.44), and Wendy Mcdermott ($35,340.00). How much insider buying is happening at Lexicon Pharmaceuticals? Insiders have purchased a total of 28,630,176 LXRX shares in the last 24 months for a total of $73,265,383.44 bought. Lexicon Pharmaceuticals Key ExecutivesMr. Jeffrey L. Wade J.D. (Age 59)President & COO Compensation: $752.05kMr. Brian T. Crum (Age 51)Senior VP, General Counsel & Secretary Compensation: $596.48kDr. Alan J. Main Ph.D. (Age 70)Executive Vice President of Innovation & Chemical Sciences Compensation: $576.96kDr. Craig B. Granowitz M.D. (Age 59)Ph.D., Senior VP & Chief Medical Officer Compensation: $652.48kDr. Michael Exton Ph.D. (Age 54)CEO & Director Ms. Kristen L. Alexander (Age 56)Vice President of Finance & Accounting Ms. Lisa M. DeFrancesco (Age 45)Vice President of Investor Relations, Corporate Strategy & Communications Mr. Dixon TerryVice President of ComplianceMs. Carrie SiragusaVice President of MarketingMs. Desiree GendronVice President of Sales & Training More Insider Trading Tools from MarketBeat Related Companies Regulus Therapeutics Insider Transactions Verastem Insider Transactions Myriad Genetics Insider Transactions Emergent BioSolutions Insider Transactions Rigel Pharmaceuticals Insider Transactions XOMA Insider Transactions Vanda Pharmaceuticals Insider Transactions Codexis Insider Transactions Sangamo Therapeutics Insider Transactions Achieve Life Sciences Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Turbulence for Joby Shares: What's Behind the Recent Dip?UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?Sprouts Stock: Insider Sales, But Strong Bullish Signals5 Hot Small-Cap Insiders Bought at the Peak of Tariff FearsThe Top-Ranked Insider Buys From April by Market Cap This page (NASDAQ:LXRX) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexicon Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lexicon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LXRX Stock Free LXRX Stock Alerts